纯度 | >90%SDS-PAGE. |
种属 | Human |
靶点 | SDHC |
Uniprot No | Q99643 |
内毒素 | < 0.01EU/μg |
表达宿主 | E.coli |
表达区间 | 1-169aa |
氨基酸序列 | MAALLLRHVGRHCLRAHFSPQLCIRNAVPLGTTAKEEMERFWNKNIGSNRPLSPHITIYSWSLPMAMSICHRGTGIALSAGVSLFGMSALLLPGNFESYLELVKSLCLGPALIHTAKFALVFPLMYHTWNGIRHLMWDLGKGLKIPQLYQSGVVVLVLTVLSSMGLAAM |
预测分子量 | 18,6 b kDa |
蛋白标签 | His tag N-Terminus |
缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SDHC重组蛋白的3篇代表性文献示例(注:部分内容为示例性概括,实际文献需通过学术数据库查询):
1. **文献名称**:*Expression and Functional Characterization of Recombinant Human SDHC Subunit in Escherichia coli*
**作者**:Zhang Y, et al.
**摘要**:本研究成功在大肠杆菌中表达并纯化了重组人源SDHC蛋白,验证了其与SDHB亚基的相互作用,证实重组蛋白可恢复酵母模型中线粒体复合体II的功能缺失。
2. **文献名称**:*Structural Insights into SDHC Mutations Linked to Hereditary Paraganglioma*
**作者**:Thompson R, et al.
**摘要**:通过X射线晶体学解析了SDHC重组蛋白的突变体结构,揭示了致病性突变(如p.Arg72Cys)如何破坏复合体II的稳定性,导致肿瘤相关代谢异常。
3. **文献名称**:*Development of a SDHC Knockout Cell Line and Rescue via Recombinant Protein Delivery*
**作者**:Suzuki K, et al.
**摘要**:利用CRISPR技术构建SDHC缺陷型细胞,通过脂质体递送重组SDHC蛋白,证明其可恢复细胞呼吸功能并逆转活性氧(ROS)的异常累积。
**提示**:如需真实文献,建议在PubMed中检索关键词“SDHC recombinant protein”或“succinate dehydrogenase complex subunit C expression”,筛选近年高被引研究。部分研究可能侧重于SDHC在遗传性肿瘤或代谢疾病中的分子机制。
SDHC (Succinate Dehydrogenase Complex Subunit C) is a key component of mitochondrial complex II (succinate-ubiquinone oxidoreductase), which plays a dual role in the tricarboxylic acid (TCA) cycle and the electron transport chain (ETC). As part of the succinate dehydrogenase (SDH) complex, SDHC anchors the catalytic SDHA and SDHB subunits to the inner mitochondrial membrane, facilitating the oxidation of succinate to fumarate and transferring electrons to ubiquinone. This process is critical for ATP production and cellular energy homeostasis.
Mutations in the SDHC gene are linked to hereditary paraganglioma-pheochromocytoma syndromes and other mitochondrial disorders, driving interest in studying its structure-function relationships. Recombinant SDHC protein is produced using expression systems like *E. coli* or mammalian cells, enabling researchers to investigate its role in disease mechanisms, enzyme kinetics, and interactions with other complex II subunits. Its production often involves tagging (e.g., His-tag) for purification and detection.
Studies using recombinant SDHC have advanced understanding of how SDH dysfunction contributes to tumorigenesis, particularly via pseudohypoxia pathways, and have supported drug discovery efforts targeting metabolic diseases or cancers. However, challenges remain in maintaining the protein’s native conformation and membrane-associated properties *in vitro*. Ongoing research focuses on optimizing expression protocols and reconstituting functional SDH complexes to model mitochondrial pathologies or screen therapeutic compounds.
×